Q3TES0
Gene name |
Iqsec3 (Kiaa1110) |
Protein name |
IQ motif and SEC7 domain-containing protein 3 |
Names |
|
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:243621 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
648-985 (Sec7-PH domains) |
Relief mechanism |
Ligand binding |
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q3TES0
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q3TES0-F1 | Predicted | AlphaFoldDB |
66 variants for Q3TES0
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3544759385 | 78 | P>S | No | EVA | |
rs3396893969 | 135 | Q>R | No | EVA | |
rs3388854060 | 234 | A>P | No | EVA | |
rs3544780982 | 269 | R>Q | No | EVA | |
rs3388858851 | 293 | D>A | No | EVA | |
rs3396888259 | 299 | I>S | No | EVA | |
rs3397056113 | 301 | M>R | No | EVA | |
rs3397313266 | 301 | M>V | No | EVA | |
rs3388851496 | 305 | K>N | No | EVA | |
rs3397261708 | 306 | Y>* | No | EVA | |
rs3397227786 | 306 | Y>C | No | EVA | |
rs3396893996 | 355 | A>E | No | EVA | |
rs3388858102 | 380 | R>H | No | EVA | |
rs3388847374 | 419 | L>F | No | EVA | |
rs3388857581 | 456 | E>V | No | EVA | |
rs3388864074 | 458 | G>D | No | EVA | |
rs3388834979 | 463 | D>G | No | EVA | |
rs3388857626 | 482 | D>E | No | EVA | |
rs3388855258 | 500 | L>M | No | EVA | |
rs250826552 | 515 | A>T | No | EVA | |
rs223718778 | 522 | A>V | No | EVA | |
rs263894200 | 540 | Q>K | No | EVA | |
rs3388859261 | 555 | A>V | No | EVA | |
rs3544814545 | 557 | S>G | No | EVA | |
rs216863181 | 572 | V>L | No | EVA | |
rs3388858906 | 578 | E>* | No | EVA | |
rs3388857565 | 581 | E>D | No | EVA | |
rs3388821613 | 582 | G>W | No | EVA | |
rs3388859281 | 584 | K>I | No | EVA | |
rs3544776693 | 589 | G>R | No | EVA | |
rs3388821569 | 627 | Q>R | No | EVA | |
rs3388858080 | 643 | S>R | No | EVA | |
rs3388852805 | 656 | K>Q | No | EVA | |
rs3388854007 | 713 | K>E | No | EVA | |
rs3388834997 | 723 | C>Y | No | EVA | |
rs3388854053 | 728 | M>L | No | EVA | |
rs3388855321 | 741 | K>E | No | EVA | |
rs3388857622 | 747 | R>H | No | EVA | |
rs3388821604 | 748 | V>E | No | EVA | |
rs3388821634 | 749 | Q>L | No | EVA | |
rs3388864097 | 749 | Q>S | No | EVA | |
rs3388851489 | 754 | K>N | No | EVA | |
rs3388851553 | 778 | H>N | No | EVA | |
rs3388864087 | 790 | I>M | No | EVA | |
rs3388845462 | 817 | L>P | No | EVA | |
rs231278348 | 844 | K>R | No | EVA | |
rs3388854062 | 846 | N>H | No | EVA | |
rs3388839260 | 881 | F>L | No | EVA | |
rs3388858104 | 890 | Q>L | No | EVA | |
rs3388859222 | 891 | K>I | No | EVA | |
rs3388850868 | 895 | H>Q | No | EVA | |
rs3388841646 | 902 | F>I | No | EVA | |
rs45636588 | 906 | L>F | No | EVA | |
rs3388859214 | 922 | T>I | No | EVA | |
rs3388850828 | 930 | L>F | No | EVA | |
rs3397148117 | 944 | H>R | No | EVA | |
rs3388855261 | 964 | C>Y | No | EVA | |
rs3388854043 | 966 | L>V | No | EVA | |
rs3388855314 | 1050 | Q>H | No | EVA | |
rs3388849935 | 1067 | P>S | No | EVA | |
rs3412781027 | 1097 | P>L | No | EVA | |
rs3388852761 | 1104 | V>I | No | EVA | |
rs3397313265 | 1115 | L>Q | No | EVA | |
rs3388821592 | 1121 | A>T | No | EVA | |
rs3388858073 | 1139 | S>P | No | EVA | |
rs3388858822 | 1146 | P>S | No | EVA |
No associated diseases with Q3TES0
8 GO annotations of cellular component
Name | Definition |
---|---|
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
GABA-ergic synapse | A synapse that uses GABA as a neurotransmitter. These synapses are typically inhibitory. |
glycinergic synapse | A synapse that uses glycine as a neurotransmitter. |
inhibitory synapse | A synapse in which an action potential in the presynaptic cell reduces the probability of an action potential occurring in the postsynaptic cell. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
postsynaptic density | An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components. |
postsynaptic membrane | A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane. |
postsynaptic specialization of symmetric synapse | A network of proteins within and adjacent to the postsynaptic membrane of a symmetric synapse, consisting of anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components that spatially and functionally organize the neurotransmitter receptors at the synapse. This structure is not as thick or electron dense as the postsynaptic densities found in asymmetric synapses. |
1 GO annotations of molecular function
Name | Definition |
---|---|
guanyl-nucleotide exchange factor activity | Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions. |
4 GO annotations of biological process
Name | Definition |
---|---|
actin cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. |
postsynapse organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a postsynapse. |
regulation of ARF protein signal transduction | Any process that modulates the frequency, rate or extent of ARF protein signal transduction. |
regulation of small GTPase mediated signal transduction | Any process that modulates the frequency, rate or extent of small GTPase mediated signal transduction. |
13 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q5JU85 | IQSEC2 | IQ motif and SEC7 domain-containing protein 2 | Homo sapiens (Human) | EV |
Q6DN90 | IQSEC1 | IQ motif and SEC7 domain-containing protein 1 | Homo sapiens (Human) | EV |
Q9UPP2 | IQSEC3 | IQ motif and SEC7 domain-containing protein 3 | Homo sapiens (Human) | SS |
Q80YW0 | Cyth4 | Cytohesin-4 | Mus musculus (Mouse) | SS |
G3X9K3 | Arfgef1 | Brefeldin A-inhibited guanine nucleotide-exchange protein 1 | Mus musculus (Mouse) | PR |
A2A5R2 | Arfgef2 | Brefeldin A-inhibited guanine nucleotide-exchange protein 2 | Mus musculus (Mouse) | PR |
O08967 | Cyth3 | Cytohesin-3 | Mus musculus (Mouse) | EV |
Q8R0S2 | Iqsec1 | IQ motif and SEC7 domain-containing protein 1 | Mus musculus (Mouse) | SS |
P63034 | Cyth2 | Cytohesin-2 | Mus musculus (Mouse) | SS |
Q9QX11 | Cyth1 | Cytohesin-1 | Mus musculus (Mouse) | SS |
Q5DU25 | Iqsec2 | IQ motif and SEC7 domain-containing protein 2 | Mus musculus (Mouse) | SS |
A0A0G2JUG7 | Iqsec1 | IQ motif and SEC7 domain-containing protein 1 | Rattus norvegicus (Rat) | SS |
Q76M68 | Iqsec3 | IQ motif and SEC7 domain-containing protein 3 | Rattus norvegicus (Rat) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MESLLENPVR | AVLYLKELTA | IVQNQQSLIH | TQRQRIDELE | RRLDELSAEN | RSLWEHQQLL |
70 | 80 | 90 | 100 | 110 | 120 |
QAQPPPGLVP | PPPSAPLPAP | AVTAPAAAAA | QEPLQDHGQL | IPASPEPPLQ | HHGQLLAQPQ |
130 | 140 | 150 | 160 | 170 | 180 |
PAPSSRVQTP | QSPHQHPVAP | GAIADKEKER | PSSCCAAAGA | LLQHASPAAL | GKGVLSRRPE |
190 | 200 | 210 | 220 | 230 | 240 |
NETVLHQFCC | PAADTEQKPA | CSDLASQSDG | SCAQAGGGME | DSVVAAVAAG | RPSAHAPKAQ |
250 | 260 | 270 | 280 | 290 | 300 |
APELQQEEER | PGAVGSPRAG | PLRAASPGRQ | QPALATALCS | HTPAASEYEL | SLDLKNKQIE |
310 | 320 | 330 | 340 | 350 | 360 |
MLEHKYGGHL | VSRRAACTIQ | TAFRQYQLSK | NFEKIRNSLL | ESRLPRRISL | RKVRAPTAES |
370 | 380 | 390 | 400 | 410 | 420 |
LVAEKALLEG | CGLLGLPLGR | SPSLPPTFAG | SLTELEDSFT | EQVQSLAKSI | DDALSTWSLK |
430 | 440 | 450 | 460 | 470 | 480 |
TMCSLQESGA | YQLHQALHPS | AGQPGLETEA | AAREPESGPG | SGDEAGGLPQ | GHSGTLMMAF |
490 | 500 | 510 | 520 | 530 | 540 |
RDVTVQIANQ | NISVSSSTAL | SVANCLGAQT | AQATAEPAAA | QAEQEDTADQ | EVSEVPASEQ |
550 | 560 | 570 | 580 | 590 | 600 |
MDPPSEDSEA | AESRAQSAQE | PAVAQAVVEE | AVATEAEEEE | EGAKQAGKGA | EAEGGDNSEQ |
610 | 620 | 630 | 640 | 650 | 660 |
LSSSSASTKS | AKSSSEASAA | ASKEALQAVI | LSLPRYHCEN | PASCRSPTLS | TDTLRKRLYR |
670 | 680 | 690 | 700 | 710 | 720 |
IGLNLFNINP | DKGIQFLISR | GFIPDTPIGV | AHFLLQRKGL | SRQMIGEFLG | NSKKQFNRDV |
730 | 740 | 750 | 760 | 770 | 780 |
LDCVVDEMDF | SNMELDEALR | KFQAHIRVQG | EAQKVERLIE | AFSQRYCMCN | PEVVQQFHNP |
790 | 800 | 810 | 820 | 830 | 840 |
DTIFILAFAI | ILLNTDMYSP | NIKPDRKMML | EDFIRNLRGV | DDGADIPREL | VVGIYERIQQ |
850 | 860 | 870 | 880 | 890 | 900 |
KELKSNEDHV | TYVTKVEKSI | VGMKTVLSMP | HRRLVCCSRL | FEVTDVNKLQ | KQAAHQREVF |
910 | 920 | 930 | 940 | 950 | 960 |
LFNDLLVILK | LCPKKKSSFT | YTFCKAVGLL | GMRFHLFENE | YYSHGITLAT | PLSGSEKKQV |
970 | 980 | 990 | 1000 | 1010 | 1020 |
LHFCALGSDE | MQKFVEDLKE | SIAEVTELEQ | IRIEWELEKQ | QGTKTLSVRS | AGAQGDPQSK |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
QGSPTAKREA | MAGEKAAESS | GEVSIHNRLQ | TSQHSPKLGV | ERGAPAPSPP | TSPPPLPPDP |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
QPSPLREQPP | PLPLPPPTPP | GTLVQCQQIV | KVIVLDKPCL | ARMEPLLSQA | LSCYASSSSD |
1150 | 1160 | 1170 | 1180 | 1190 | |
SCGSTPLRGP | GSPVKVIHQP | PLPPPPPPYN | HPHQFCPPGS | MLLRRRYSSG | SRSLV |